CIK: 0001121404 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 11, 2026
Total Value ($000): $310,415 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics Inc. | 912,041 | $16,020 | 5.2% | $16.75 | 0.0% | COM | 56565P103 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OMDA | Omada Health Inc. | 524,903 | $11,606 | 3.7% | $17.31 | +17.2% | — | 68170A108 |
| — | LAVA Therapeutics N.V. | 1,919,455 | $2,994 | 1.0% | $0.95 | — | — | N51517105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | 1,157,926 | $91,476 | 29.5% | $15.23 | +347.3% | COM | 45720N103 |
| ANAB | AnaptysBio | 821,917 | $39,847 | 12.8% | $24.22 | +60.9% | COM | 032724106 |
| NVAX | Novavax | 6,880,481 | $46,237 | 14.9% | $9.64 | -21.8% | COM NEW | 670002401 |
| MGTX | MeiraGTx Holdings plc | 12,197,737 | $96,972 | 31.2% | $5.86 | +41.8% | COM | G59665102 |
| IMRX | Immuneering Corp | 2,708,559 | $17,822 | 5.7% | $5.19 | +23.7% | CLASS A COM | 45254E107 |
| ELDN | Eledon | 814,980 | $1,231 | 0.4% | $3.94 | -39.7% | COM | 28617K101 |
| QTTB | Q32 Bio Inc. | 244,083 | $810 | 0.3% | $31.58 | -91.0% | COM | 746964105 |